Tranexamic acid in endoscopic sinus and skull base surgery: A systematic review and meta‐analysis
International Forum of Allergy & Rhinology · 2023
DOI: 10.1002/alr.23203 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Forum of Allergy & Rhinology, 2023. Verfasst von Zahra Abdallah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents, Paranasal Sinuses. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Endoscopic sinus surgery (ESS) and endoscopic skull base surgery (ESBS) approaches have revolutionized the management of sinonasal and intracranial pathology. Maintaining surgical hemostasis is essential as bleeding can obscure the visibility of the surgical field, thus increasing surgical duration, risk of complications, and procedural failure. Tranexamic acid (TXA) acts to reduce bleeding by inhibiting fibrin degradation. This review aims to assess whether TXA improves surgical field quality and reduces intraoperative blood loss compared with control.
Methods
We searched PubMed, MEDLINE, Embase, Web of Science, and Cochrane Library from inception until September 1, 2022. Two reviewers independently screened citations, extracted data, and assessed methodological quality using the Cochrane risk‐of‐bias tool for randomized trials. Data were pooled using a random‐effect model, with continuous data presented as mean differences and dichotomous data presented as odds ratios.
Results
Seventeen ESS randomized controlled trials ( n = 1377) and one ESBS randomized controlled trial ( n = 50) were reviewed. Significant improvement in surgical field quality was achieved with both systemic TXA (six studies, p < 0.00001) and topical TXA (six studies, p = 0.01) compared with the control. Systemic TXA (eight studies) and topical TXA (three studies) both achieved a significant reduction in intraoperative blood loss compared with the control ( p < 0.00001). There were significant differences in operative times ( p < 0.001) but no significant difference in perioperative outcomes ( p = 0.30).
Conclusion
This meta‐analysis demonstrated that the administration of TXA in ESS can improve surgical field quality and reduce intraoperative blood loss. TXA use did not result in increased perioperative complications including thrombotic events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Department of Surgery, Division of Otolaryngology, Head & Neck Surgery, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Zahra Abdallah, Kelvin Zhou, Sarah Khalife
Zitieren
APA
Abdallah, Z., Staibano, P., Zhou, K., Khalife, S., Nguyen, T. B. V., & Sommer, D. D. (2023). Tranexamic acid in endoscopic sinus and skull base surgery: A systematic review and meta‐analysis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23203
Vancouver
Abdallah Z, Staibano P, Zhou K, Khalife S, Nguyen TBV, Sommer DD. Tranexamic acid in endoscopic sinus and skull base surgery: A systematic review and meta‐analysis. International Forum of Allergy & Rhinology. 2023. doi:10.1002/alr.23203
BibTeX
@article{Abdallah2023,
author = {Abdallah, Zahra and Staibano, Phillip and Zhou, Kelvin and Khalife, Sarah and Nguyen, Thomas B V and Sommer, Doron D},
title = {Tranexamic acid in endoscopic sinus and skull base surgery: A systematic review and meta‐analysis},
journal = {International Forum of Allergy & Rhinology},
year = {2023},
doi = {10.1002/alr.23203}
}
EUVIMED